Ghent University Academic Bibliography

Your filters: cql: author="Eichau, Sara" or (type any "bookEditor issueEditor" and editor="Eichau, Sara")

Add to list
- Journal Article
- A2
- open access
Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase

Tim Spelman, Sara Eichau, Raed Alroughani, Serkan Ozakbas, Samia J Khoury, Francesco Patti, Eva Kubala Havrdova, Cavit Boz, Murat Terzi, Jens Kuhle, et al.

(2024) MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL TRANSLATIONAL AND CLINICAL. 10(2). p.1-13
Add to list
- Journal Article
- A1
- open access
A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Anoushka P. Lal, Yi Chao Foong, Paul G. Sanfilippo, Tim Spelman, Louise Rath, David Levitz, Marzena Fabis-Pedrini, Matteo Foschi, Mario Habek, Tomas Kalincik, et al.

(2024) JOURNAL OF NEUROLOGY. 271. p.5813-5824
Add to list
- Journal Article
- A1
- open access
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies

Ying Li, Alice Saul, Bruce Taylor, Anne-Louise Ponsonby, Steve Simpson-Yap, Leigh Blizzard, Simon Broadley, Jeannette Lechner-Scott, Rana Karabudak, Francesco Patti, et al.

(2024) JOURNAL OF NEUROLOGY. 271. p.472-485
Add to list
- Journal Article
- A2
- open access
Machine-learning-based prediction of disability progression in multiple sclerosis : an observational, international, multi-center study

Edward De Brouwer, Thijs Becker, Lorin Werthen-Brabants (UGent) , Pieter Dewulf, Dimitrios Iliadis (UGent) , Cathérine Dekeyser (UGent) , Guy Laureys (UGent) , Bart Van Wijmeersch, Veronica Popescu, Tom Dhaene (UGent) , et al.

(2024) PLOS DIGITAL HEALTH. 3(7).
Add to list
- Journal Article
- A1
- open access
Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries

Sifat Sharmin, Izanne Roos, Charles B Malpas, Pietro Iaffaldano, Marta Simone, Massimo Filippi, Eva Kubala Havrdova, Serkan Ozakbas, Vincenzo Brescia Morra, Raed Alroughani, et al.

(2024) LANCET CHILD & ADOLESCENT HEALTH. 8(5). p.348-357
Add to list
- Journal Article
- A1
- open access
Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation

Chao Zhu, Tomas Kalincik, Dana Horakova, Zhen Zhou, Katherine Buzzard, Olga Skibina, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Jens Kuhle, et al.

(2023) JAMA NEUROLOGY. 80(7). p.739-748
Add to list
Comparative effectiveness in multiple sclerosis : a methodological comparison

Izanne Roos, Ibrahima Diouf, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, et al.

(2023) MULTIPLE SCLEROSIS JOURNAL. 29(3). p.326-332
Add to list
- Journal Article
- A1
- open access
Disability accrual in primary and secondary progressive multiple sclerosis

Sam Harding-Forrester, Izanne Roos, Ai-Lan Nguyen, Charles B Malpas, Ibrahima Diouf, Nahid Moradi, Sifat Sharmin, Guillermo Izquierdo, Sara Eichau, Francesco Patti, et al.

(2023) JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 94(9). p.707-717
Add to list
- Journal Article
- A1
- open access
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

Ibrahima Diouf, Charles B. Malpas, Sifat Sharmin, Izanne Roos, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, et al.

(2023) EUROPEAN JOURNAL OF NEUROLOGY. 30(4). p.1014-1024
Add to list
- Journal Article
- A1
- open access
Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

Izanne Roos, Stella Hughes, Gavin McDonnell, Charles B. Malpas, Sifat Sharmin, Cavit Boz, Raed Alroughani, Serkan Ozakbas, Katherine Buzzard, Olga Skibina, et al.

(2023) JAMA NEUROLOGY. 80(8). p.789-797

Academic Bibliography

Comparative effectiveness of dimethyl fumarate versus non-specific immunosuppressants : real-world evidence from MSBase

A multi-centre longitudinal study analysing multiple sclerosis disease-modifying therapy prescribing patterns during the COVID-19 pandemic

Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis : recruitment challenges, potential bias, and statistical strategies

Machine-learning-based prediction of disability progression in multiple sclerosis : an observational, international, multi-center study

Disease-modifying therapies in managing disability worsening in paediatric-onset multiple sclerosis : a longitudinal analysis of global and national registries

Comparison between dimethyl fumarate, fingolimod, and ocrelizumab after natalizumab cessation

Comparative effectiveness in multiple sclerosis : a methodological comparison

Disability accrual in primary and secondary progressive multiple sclerosis

Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis

Rituximab vs ocrelizumab in relapsing-remitting multiple sclerosis

Contents

Support

Contact